amikacin has been researched along with Neutropenia in 166 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 46 (27.71) | 18.7374 |
| 1990's | 57 (34.34) | 18.2507 |
| 2000's | 49 (29.52) | 29.6817 |
| 2010's | 13 (7.83) | 24.3611 |
| 2020's | 1 (0.60) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmad, MN; Chopra, S; Dasgupta, A; Garg, T; Kaur, P; Krishnamurthy, RV; Malik, P; Shukla, R; Singh, S | 1 |
| Cho, B; Chung, NG; Han, SB; Jeong, DC; Kang, JH; Kim, HS; Kim, SK; Lee, DG; Lee, JW; Park, BK | 1 |
| Chopra, S; Das, S; Dasgupta, A; Karaulia, P; Pandey, AK; Pandey, M; Singh, AK; Soni, I; Thakare, R | 1 |
| Böttger, EC; Freihofer, P; Lenaerts, A; Meyer, M; Scherman, M; Teague, J | 1 |
| Agudelo, M; Rodriguez, CA; Vesga, O; Zuluaga, AF | 1 |
| Giannakakis, T; Hatzitolios, A; Kollaras, P; Kordosis, T; Metallidis, S; Nikolaidis, J; Nikolaidis, P; Seitanidis, B | 1 |
| Carlesse, FA; da Silva, KV; de Martino Lee, ML; Luisi, FA; Pereira, CA; Petrilli, AS | 1 |
| Jeon, K; Kim, BJ; Kim, CK; Koh, WJ; Kook, YH; Kwon, OJ; Lee, NY; Lee, SH; Park, YK | 1 |
| Agarwala, S; Bakhshi, S; Gupta, A; Pandey, RM; Swaroop, C | 1 |
| Berneman, ZN; Goossens, H; Mebis, J | 1 |
| Bastús, R; Cirera, L; Estany, C; Estrada, C; Garau, J; Gómez, I; Gómez, L; Márquez, M; Martí, JM; Quintana, S | 1 |
| Akduman, D; Ankarali, H; Aydemir, H; Celebi, G; Engin, H; Gokmen, A; Keskin, AS; Oztoprak, N; Piskin, N | 1 |
| Kılıç, SC; Sarper, N; Zengin, E | 1 |
| Landau, Z; Miller, EB; Shichmanter, R; Shtalrid, M | 1 |
| Bompolaki, I; Bozionelou, V; Falagas, ME; Kalpadaki, C; Karageorgopoulos, DE; Koutsounaki, E; Mitsikostas, P; Samonis, G; Sgouros, J; Taktikou, V | 1 |
| Alfandari, S; Allorge, D; Berthon, C; Blondiaux, N; Cliquennois, E; Gay, J; Herbaux, C; Mareville, J; Pasquier, F | 1 |
| Chaffanel-Peláez, M; Del Boz, J; Serrano-Martín, MM; Vera-Casaño, A | 1 |
| Celebi, S; Demirkaya, M; Hacımustafaoglu, M; Sevinir, B | 1 |
| Ben-Shimol, S; Fruchtman, Y; Greenberg, D; Hazan, G; Kapelushnik, J; Leibson, T | 1 |
| Aparicio, J; Bosch, C; Galan, A; Giner, V; Juan, O; Molins, C; Montalar, J; Segura, A | 1 |
| Barr-Alí, M; Burgaleta, C; De Miguel, D; García-Suárez, J; Hernanz, N; Krsnik, I; Reyes, E | 1 |
| Casimir, L; Debbag, R; Fraquelli, L; Gómez, S; Iturres, AS; Latella, A; Paganini, H; Ruvinsky, S; Zubizarreta, P | 1 |
| Blot, N; Marie-Cardine, A; Schneider, P; Tron, P; Vannier, JP | 1 |
| Casini, C; Fanci, R; Leoni, F; Longo, G; Paci, C | 1 |
| Afif, C; Boktour, MR; Escalante, C; Hachem, RY; Hanna, HA; Husni, R; Jacobson, K; Kantarjian, H; Kontoyiannis, D; Levett, LM; Raad, II; Rolston, KV; Whimbey, EE | 1 |
| Cypriano, M; Dantas, LS; Lee, LM; Petrilli, AS; Pires Pereira, CA; Torres B Silva, KV; Vercillo Luisi, MF | 1 |
| Abdulkadyrov, KM; Chebotkevich, VN; Chudanova, TV | 1 |
| Chiu, HH; Hung, KC; Lin, HC; Peng, CT; Tsai, FJ; Tseng, YC; Wang, JH | 1 |
| Aksoylar, S; Cetingül, N; Kansoy, S; Kantar, M; Karapinar, D; Kavakli, K | 1 |
| Akiyama, N; Imajo, K; Masaoka, T; Ohyashiki, K; Suzuki, K; Tamura, K; Tanimoto, M; Urabe, A | 1 |
| Ohyashiki, K | 1 |
| Ahmed, U; Burney, IA; Khan, MA; Shamim, A; Siddiqui, BK; Yosuf, MA; Zakiullah, N | 1 |
| Giltri, G; Isella, M; Larocca, A; Marinoni, S; Miccolis, I; Parma, M; Pogliani, EM; Rossini, F; Terruzzi, E; Verga, L | 1 |
| Bermúdez, A; Besalduch, J; Nocea, G; Pascual, MJ; Rovira, M; Sanz, MA; Sanz-Rodríguez, C | 1 |
| Takata, T; Tamura, K | 1 |
| Aydogdu, I; Ersoy, Y; Kaya, E; Kuku, I; Serefhanoglu, K; Serefhanoglu, S | 1 |
| Alexaki, P; Christakis, GB; Megalakaki, A; Perlorentzou, S; Zarkadis, IK | 1 |
| Amador, ML; Arcediano, A; Bazares, S; Castellano, D; Ciruelos, E; Cortés-Funes, H; González-Cortijo, L; Hornedo, J; Jimeno, A; Lumbreras, C; Paz-Ares, L; Robles, L | 1 |
| Ahmed, IA; Ahmed, N; El-Beshlawy, A; El-Haddad, A; El-Mahallawy, HA; Nassif, S | 1 |
| Rosoff, PM; Saini, S | 1 |
| Hamidah, A; Jamal, R; Lim, YS; Nordiah, AJ; Zarina, AL; Zulkifli, SZ | 1 |
| Laoprasopwattana, K; Laosombat, V; Pruekprasert, P; Wongchanchailert, M | 1 |
| Hamidah, A; Jamal, R; Nordiah, AJ; Rizal, AM | 1 |
| Aytac, S; Cengiz, AB; Cetin, M; Ceyhan, M; Secmeer, G; Tuncer, M; Yetgin, S; Yildirim, I | 1 |
| Fasching, CE; Gerding, DN; Moody, JA; Peterson, LR | 4 |
| Carpenter, JL; Troxell, M; Wallace, RJ | 1 |
| Klastersky, J; Lagast, H; Meunier, F; Piccart, M; Van Laethem, Y; Weerts, D | 1 |
| Lönnqvist, B; Palmblad, J | 1 |
| Dupont, J; Fernández, A; Garay, G; López, H; Marcenac, F; Pavlovsky, S; Scaglione, C | 1 |
| Cafarelli, A; Cruciani, M; Magliulo, E; Piantieri, G | 1 |
| Hindler, J; Martin, WJ; Meyer-Dudnik, PV; Young, LS | 1 |
| Klastersky, J | 2 |
| Deshpande, GN; Ettinger, LJ; Faden, HS; Freeman, AI; Grossi, M; Surgalla, M | 1 |
| Costa, MA; Martins, CA; Nucci, M; Velasco, E | 1 |
| Bucaneve, G; Buelli, M; Carotenuto, M; D'Antonio, D; Gentile, G; Liso, V; Martino, P; Menichetti, F; Nosari, AM; Ricci, P | 1 |
| Allin, R; Folb, PI; Zent, CS | 1 |
| Cony-Makhoul, P; Fière, D; Guy, H; Herbrecht, R; Marie, JP; Milpied, N; Pico, JL; Plantier, I; Vekhoff, A | 1 |
| Aswapokee, N; Chayakul, P; Chuncharunee, S; Leelasuphasri, S; Sathapatayavongs, B; Siritanaratkul, N; Suwangool, P | 1 |
| Bolis, S; Bregani, R; Casaroli, I; Corneo, G; Lanzi, E; Mingozzi, S; Pioltelli, P; Pogliani, EM; Rossini, F; Viganó, F | 1 |
| de Oliveira, HP; Nucci, M; Pulcheri, WA; Spector, N | 1 |
| Eguchi, K; Kojima, A; Ohe, Y; Okamoto, H; Oshita, F; Saijo, N; Sasaki, Y; Shinkai, T; Soejima, Y; Tamura, T | 1 |
| Andremont, A; Chiche, D; Guiguet, M; Hayat, M; Lagrange, P; Lapierre, V; Marie, JP; Pico, JL; Richet, H; Tancrede, C | 1 |
| Danisovicová, A; Drgona, L; Fuchsberger, P; Korec, S; Krcméry, V; Spánik, S; Svec, J | 1 |
| Cunha, BA; Domenico, P; Straus, DC; Woods, DE | 1 |
| Gentile, G; Girmenia, C; Martino, P; Meloni, G; Micozzi, A; Nucci, M; Venditti, M | 1 |
| Benne, CA; Bruin, M; de Hoog, GS; Fleer, A; Neeleman, C | 1 |
| Acuña, G; Duhalde, M; Grebe, G; Labarca, J; Lira, P; Ocqueteau, M; Oliva, J; Pérez, C; Sirham, M | 1 |
| Atkinson, SA; Barr, RD; Halton, JM; Wu, B | 1 |
| Blaise, D; Cordonnier, C; Espinouse, D; Herbrecht, R; Leblond, V; Minozzi, C; Sadoun, A; Sauvage, C | 1 |
| Biard, O; Casassus, P; Guillevin, L; Lortholary, O; Padoin, C; Petitjean, O; Rizzo, N; Tod, M | 1 |
| Deweerdt, C; Maire, P; Pivot-Dumarest, C; Roux, D; Sorensen, P; Troncy, J | 1 |
| Bjökholm, M; Engervall, P; Günther, G; Hast, R; Kalin, M; Ljungman, P; Lönnqvist, B; Ringertz, S; Stiernstedt, G | 1 |
| Aulagner, G; Barbé, G; Bertrand, Y; Bréant, V; Dürr, F; Nakache, C; Vray, C | 1 |
| Cordonnier, C; Delain, M; Delmer, A; Gardembas, M; Gres, JJ; Herbrecht, R; Ladeb, S; Moreau, P; Nalet, V; Pico, JL; Rollin, C | 1 |
| Charnas, R; Lüthi, AR; Ruch, W | 1 |
| Bayle, C; Bourhis, JH; Cartron, J; Gautier, E; Pico, JL; Tchernia, G | 1 |
| Behre, G; Hiddemann, W; Link, H; Maschmeyer, G; Meyer, P; Paaz, U; Wilhelm, M | 1 |
| Casassus, P; Guillevin, L; Lortholary, O; Petitjean, O; Semaoun, R; Seytre, D; Tod, M; Uzzan, B | 1 |
| McClure, JT; Rosin, E | 1 |
| Andremont, A; Guy, H; Marie, JP; Pico, JL; Richet, H; Vekhoff, A | 1 |
| Böhme, C; Hess, U; Rey, K; Senn, HJ | 1 |
| Berneman, ZN; Bruyneel, P; Goossens, H; Mebis, J; Meeus, I; Schroyens, W; Sion, JP; Van Droogenbroeck, J | 1 |
| Belmont-Martinez, L; Bernaldez-Rios, R; Miranda-Novales, MG; Penagos-Paniagua, M; Solorzano-Santos, F; Villasis-Keever, MA | 1 |
| Krcmery, V; Krupova, Y; Mateicka, F; Novotny, J; Sabo, A | 1 |
| Colomer, R; Cortés-Funes, H; García-Carbonero, R; Gómez, C; Hidalgo, M; Hornedo, J; Lumbreras, C; Perea, S; Ruiz, A; Trigo, JM | 1 |
| Caballero, D; Encinas, MP; García-Sanz, R; Gutiérrez, N; Hurlé, AD; Morín, LS; Vázquez, L; Vilches, P | 1 |
| Alimena, G; Battistini, R; Breccia, M; Celesti, F; Cimino, G; Coppola, L; Girmenia, C; Latagliata, R; Mandelli, F; Morano, SG; Spadea, A; Tafuri, A; Tosti, S | 1 |
| Başkan, S; Ozyilkan, O; Yalçintaş, U | 1 |
| Bacci, S; Bosi, A; Fanci, R; Guidi, S; Laszlo, D; Rossi-Ferrini, P; Saccardi, R; Vannucchi, AM | 1 |
| Caballero, D; Calvo, MV; Dominguez-Gil, A; Fdez de Gatta, MM; Lanao, JM; Romano, S | 1 |
| Alimena, G; Celesti, F; Cimino, G; Coppola, L; D'Elia, GM; Girmenia, C; Latagliata, R; Mandelli, F; Mecarocci, S; Morano, SG; Spadea, A; Tafuri, A; Tosti, S | 1 |
| Akan, H; Akova, M; Biberoğlu, K; Hayran, M; Kansu, E; Kars, A; Korten, V; Unal, S | 1 |
| Chastagner, P; Eyer, D; Lozniewski, A; Plesiat, P; Plouvier, E; Sommelet, D | 1 |
| Armada, AA; Casimir, L; De Martino, MG; Debbag, R; Fernandez, C; Paganini, HR; Rodriguez-Brieshcke, MT; Sarkis, CM; Zubizarreta, PA | 1 |
| Fabbri, A; Fanci, R; Leoni, F; Longo, G; Martinez, RL; Paci, C; Pecile, P | 1 |
| Aznar, E; Climent, MA; Máiquez, J; Palau, J; Picón, I | 1 |
| Arasu, A; Ariffin, H; Ariffin, WA; Chan, LL; Lin, HP; Mahfuzah, M | 1 |
| Engervall, P; Persson, L; Sjöberg, L; Tidefelt, U; Vikerfors, T | 1 |
| Armada, A; Cáceres, E; Casimir, L; Debbag, R; Fernández, C; Firpo, V; Latella, A; Paganini, H; Rodriguez-Brieshcke, T; Zubizarreta, P | 1 |
| Bessho, M; Endo, K; Fukuda, M; Hirasima, K; Ito, K; Kawai, N; Tominaga, K | 1 |
| Boffa, ML; De Blasi, D; Mastrullo, L; Miraglia, E; Orlando, R; Zorzato, G | 1 |
| Agaoglu, L; Agirbasli, H; Anak, S; Bilgen, H; Biner, B; Can, M; Devecioglu, O; Eryilmaz, E; Gedikoglu, G; Goksan, B; Karakas, Z; Unuvar, A; Yalman, N | 1 |
| Bucaneve, G; D'Antonio, D; Del Favero, A; Furno, P; Gentile, G; Mandelli, F; Martino, B; Martino, P; Menichetti, F; Micozzi, A; Ricci, P; Russo, D | 1 |
| Baka, M; Gombakis, N; Kafetzis, DA; Koliouskas, DE; Kosmidou, H; Malaka-Zafiriou, E; Maltezou, HC | 1 |
| Akan, H; Akova, M; Cetinkaya, Y; Erman, M; Ferhanoğlu, B; Köksal, I; Korten, V; Unal, S; Uzun, O | 1 |
| Landau, M; Nucci, M; Pulcheri, W; Silveira, F; Spector, N | 1 |
| Cid, A; Jarque, I; Martín, G; Pérez-Bellés, C; Salavert, M; Sanz, MA | 1 |
| Acevedo, A; Escudero, A; Fernández-Rañada, JM; Gil-Fernández, JJ; Martínez, E; Martínez-Chamorro, C | 1 |
| Brennscheidt, U; Cornely, O; Figuera, A; Glauser, MP; Grigg, A; Keyserling, C; Tack, K; Trostmann, U; Welling, L | 1 |
| Anguita, A; Loscos, J; Serra, A; Vila, M; Vivancos, J | 1 |
| Batlle, M; Benlloch, L; Capote, FJ; Gutiérrez, M; Jarque, I; Julià, A; Lahuerta, JJ; Larrea, L; López, J; Palau, J; Pérez, C; Ramos, F; Rovira, M; Sanz, MA; Vázquez, L | 1 |
| Coiffier, B; Espinouse, D; Felman, P; Fiere, D; Reynaud, J; Vialard, L; Vu Van, H | 1 |
| Hairston, J; Sidell, J; Winston, DJ; Young, LS | 1 |
| Bodey, GP; Keating, MJ; Rodriguez, V; Valdivieso, M | 1 |
| Gisselbrecht, C; Marty, M; Samson-Lepors, MJ | 1 |
| Kowarski, A; Lietman, PS; Vogelstein, B | 1 |
| Abbas, Z; Karim, M; Malik, IA | 1 |
| Ajarim, DS; al Mohareb, F; al Momen, AK; Harakati, MS; Santhosh-Kumar, CR; Zeitany, RG | 1 |
| Gentile, G; Girmenia, C; Mandelli, F; Martino, P; Micozzi, A; Raccah, R | 1 |
| Artal, A; Berrocal, A; Chacón, I; Espinosa, E; Feliu, J; García de Paredes, ML; González Barón, M; Montero, JM; Ordóñez, A; Zamora, P | 1 |
| Bosseray, A; Brion, JP; Hollard, D; Michallet, M; Micoud, M; Nicolini, F; Stahl, JP | 1 |
| Cimino, G; Gentile, G; Girmenia, C; Martino, P; Micozzi, A; Raccah, R; Sgadari, C | 1 |
| Kibbler, CC; McWhinney, PH; Prentice, HG; Warner, P | 1 |
| Björkholm, MJ; Engervall, PA; Günther, GC; Stiernstedt, GT | 1 |
| Hirose, T; Kumamoto, Y; Tanaka, N; Yokoo, A | 1 |
| Anaissie, EJ; Berkey, P; Bodey, GP; Cabanillas, FF; Elting, L; Holmes, FA; Joshi, JH; Keating, MJ; Khardori, NM; Rolston, KV | 1 |
| Anak, S; Devecioğlu, O; Gedikoğlu, G; Ovali, F; Zülfikar, B | 1 |
| Avlami, A; Meletis, J; Rombos, Y; Vayopoulos, G; Yataganas, X | 1 |
| Bauters, F; Blanc, C; Pollet, JP | 1 |
| Davis, RL; Lehmann, D; Neidhart, J; Stidley, CA | 1 |
| Amadori, S; Martino, P; Micozzi, A; Pulsoni, A; Tirindelli, C; Venditti, M | 1 |
| Aversa, F; Bucaneve, G; Del Favero, A; Fiorio, M; Menichetti, F | 1 |
| Bodey, GP; Elting, L; Fainstein, V; Rosenbaum, B | 1 |
| Abumelha, A; al-Fadil, M; al-Mulhim, I; Sumer, T | 1 |
| Baker, DK; Goren, MP; Shenep, JL | 1 |
| Bodunkova, LE; Ivanitskaia, LP; Kudinova, MK; Samoĭlova, LN; Viadro, MM | 1 |
| Arnow, P; Edlin, B; Flaherty, JP; George, D; O'Keefe, P; Waitley, D; Weinstein, RA | 1 |
| Benn, R; Benson, W; Date, L; Gibson, J; Iland, H; Joshua, DE; Kronenberg, H; Vincent, PC; Wilson, A; Young, GA | 1 |
| Benedetti, M; Gasparini, G; Talamini, R; Toffoli, G; Tumolo, S; Vaglia, A | 1 |
| Angelini, A; Betti, S; D'Antonio, D; Dell'Isola, M; di Girolamo, A; Dragani, A; Fioritoni, G; Iacone, A; Piccolomini, R | 1 |
| Agaliotis, D; Ezzeddine, H; Gala, JL; Gigi, J; Michaux, JL; Vandercam, B; Wauters, G | 1 |
| Brice, P; Calvo, F; de Castro, H | 1 |
| Brion, JP; Bru, JP; Corron, B; Fauconnier, J; Michallet, M | 1 |
| Ajchenbaum, F; Baume, D; Chiche, D; Delmer, A; Fitoussi, F; Marie, JP; Pico, JL; Richet, H; Rio, B; Tancrède, C | 1 |
| Baker, DK; Blankenship, KR; Feldman, S; Gigliotti, F; Hughes, WT; Meyer, WH; Roberson, PK; Santana, VM; Shenep, JL; Sixbey, JW | 1 |
| Artino, RM; Dotti, G; Giacchino, M; Grazia, G; Madon, E; Mattirolo, F; Miniero, R; Vivalda, M | 1 |
| Avvisati, G; Fenu, S; Girmena, C; Martino, P; Micozzi, A; Raccah, R; Santilli, S | 1 |
| Nightingale, CH; Quintiliani, R; Shyu, WC | 1 |
| Colucci, A; Coniglio, M; Girardi, F; Guarini, A; Iaculli, L; Liso, V; Pavone, V; Specchia, G | 1 |
| Munro, R; Rawlinson, W; Sorrell, T | 1 |
| Andrien, F; Anniko, M; Baudrihaye, M; Bow, E; Burman, LA; Louie, T; Norberg, B; Norrby, SR; Runde, V; Vandercam, B | 1 |
| Croydon, E; Weerts, D | 1 |
| Chadwick, EG; Shulman, ST; Yogev, R | 2 |
| Johnson, DE; Thompson, B | 1 |
| Blaser, J; Dudley, M; Zinner, SH | 1 |
| Zinner, SH | 1 |
| Calia, FM; Johnson, DE; Thompson, B | 1 |
| Andremont, AO; Tancrède, CH | 1 |
| Shulman, ST; Yogev, R | 1 |
3 review(s) available for amikacin and Neutropenia
| Article | Year |
|---|---|
Febrile neutropenia.
Topics: Amikacin; Amphotericin B; Bacteremia; Bacterial Infections; Ceftazidime; Clinical Trials as Topic; Drug Therapy, Combination; Fever; Fever of Unknown Origin; Humans; Mycoses; Neoplasms; Neutropenia; Vancomycin; Virus Diseases | 1993 |
Acute necrotizing gastritis by Escherichia coli in a severely neutropenic patient.
Topics: Acute Disease; Amikacin; Anemia, Aplastic; Antilymphocyte Serum; Combined Modality Therapy; Cyclosporine; Drug Therapy, Combination; Escherichia coli Infections; Gastric Mucosa; Gastritis; Granulocyte Colony-Stimulating Factor; Immunosuppressive Agents; Meropenem; Methylprednisolone; Necrosis; Neutropenia; Omeprazole; Parenteral Nutrition, Total; T-Lymphocytes; Thienamycins | 2002 |
Vancomycin does not enhance amikacin-induced tubular nephrotoxicity in children.
Topics: Adolescent; Amikacin; Animals; Child; Child, Preschool; Clinical Trials as Topic; Double-Blind Method; Drug Synergism; Drug Therapy, Combination; Female; Fever; Humans; Kidney Diseases; Kidney Tubules; Male; Neutropenia; Proteinuria; Random Allocation; Rats; Ticarcillin; Vancomycin | 1989 |
90 trial(s) available for amikacin and Neutropenia
| Article | Year |
|---|---|
A prospective, controlled, randomized, non-blind, comparative study of the efficacy and safety of a once daily high dose of ceftriaxone plus ciprofloxacin versus thrice daily ceftazidime plus amikacin in empirical therapy for febrile neutropenic patients.
Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Ceftazidime; Ceftriaxone; Ciprofloxacin; Cost-Benefit Analysis; Drug Costs; Drug Therapy, Combination; Female; Fever; Greece; Humans; Male; Middle Aged; Neutropenia; Prospective Studies; Treatment Outcome | 2008 |
Cefepime monotherapy is as effective as ceftriaxone plus amikacin in pediatric patients with cancer and high-risk febrile neutropenia in a randomized comparison.
Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Cefepime; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Drug Therapy, Combination; Female; Hematologic Neoplasms; Humans; Immunocompromised Host; Infant; Male; Neutropenia; Treatment Outcome; Young Adult | 2009 |
Randomized controlled trial comparing oral amoxicillin-clavulanate and ofloxacin with intravenous ceftriaxone and amikacin as outpatient therapy in pediatric low-risk febrile neutropenia.
Topics: Administration, Oral; Adolescent; Ambulatory Care; Amikacin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Ceftriaxone; Child; Child, Preschool; Drug Therapy, Combination; Female; Fever; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Injections, Intravenous; Male; Neoplasms; Neutropenia; Ofloxacin; Treatment Outcome | 2009 |
Low-dose beta-lactam plus amikacin in febrile neutropenia: cefepime vs. piperacillin/tazobactam, a randomized trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Cefepime; Cephalosporins; Female; Fever of Unknown Origin; Humans; Incidence; Male; Middle Aged; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Poisoning; Prospective Studies; Treatment Outcome; Young Adult | 2010 |
Piperacillin-tazobactam versus carbapenem therapy with and without amikacin as empirical treatment of febrile neutropenia in cancer patients: results of an open randomized trial at a university hospital.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Antineoplastic Agents; Bacterial Infections; Carbapenems; Drug Eruptions; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Multivariate Analysis; Neoplasms; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Survival Rate; Young Adult | 2010 |
Piperacillin/tazobactam monotherapy versus piperacillin/tazobactam plus amikacin as initial empirical therapy for febrile neutropenia in children with acute leukemia.
Topics: Acute Disease; Adolescent; Amikacin; Anti-Bacterial Agents; Child; Child, Preschool; Female; Humans; Leukemia; Male; Neutropenia; Penicillanic Acid; Piperacillin; Tazobactam; Treatment Outcome; Young Adult | 2011 |
Randomized comparison of piperacillin-tazobactam plus amikacin versus cefoperazone-sulbactam plus amikacin for management of febrile neutropenia in children with lymphoma and solid tumors.
Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Cefoperazone; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Lymphoma, Non-Hodgkin; Male; Neutropenia; Penicillanic Acid; Piperacillin; Prospective Studies; Sulbactam; Tazobactam | 2013 |
Cefepime monotherapy as an empirical initial treatment of patients with febrile neutropenia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Antineoplastic Agents; Bacterial Infections; Cefepime; Cephalosporins; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Multicenter Studies as Topic; Neoplasms; Neutropenia; Teicoplanin; Treatment Outcome; Vancomycin | 2002 |
Outpatient, sequential, parenteral-oral antibiotic therapy for lower risk febrile neutropenia in children with malignant disease: a single-center, randomized, controlled trial in Argentina.
Topics: Administration, Oral; Adolescent; Ambulatory Care; Amikacin; Anti-Bacterial Agents; Antineoplastic Agents; Argentina; Ceftriaxone; Child; Child, Preschool; Ciprofloxacin; Female; Fever; Humans; Infant; Leukemia; Male; Neutropenia; Risk | 2003 |
Ticarcillin-clavulanic acid plus amikacin versus ceftazidime plus amikacin in the empirical treatment of fever in acute leukemia: a prospective randomized trial.
Topics: Adult; Aged; Amikacin; Ceftazidime; Chi-Square Distribution; Clavulanic Acids; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Fever; Follow-Up Studies; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Neutropenia; Probability; Prospective Studies; Risk Assessment; Survival Rate; Ticarcillin; Treatment Outcome | 2003 |
Treatment of febrile neutropenic patients with cancer who require hospitalization: a prospective randomized study comparing imipenem and cefepime.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Catheterization, Central Venous; Cefepime; Cephalosporins; Female; Fever; Hospitalization; Humans; Imipenem; Male; Middle Aged; Neoplasms; Neutropenia; Practice Guidelines as Topic; Prospective Studies; Risk Factors; Vancomycin | 2003 |
Evaluation of ticarcillin/clavulanic acid versus ceftriaxone plus amikacin for fever and neutropenia in pediatric patients with leukemia and lymphoma.
Topics: Adolescent; Amikacin; Bacterial Infections; Brazil; Ceftriaxone; Child; Child, Preschool; Clavulanic Acids; Drug Therapy, Combination; Epidemiologic Methods; Female; Fever; Humans; Infant; Leukemia; Lymphoma, Non-Hodgkin; Male; Neutropenia; Ticarcillin; Treatment Outcome | 2003 |
[Cefepime/amikacin in the empirical antibacterial therapy for patients with hemoblastosis of different forms].
Topics: Amikacin; Anti-Bacterial Agents; Bacterial Infections; Cefepime; Ceftriaxone; Cephalosporins; Drug Therapy, Combination; Hematologic Neoplasms; Humans; Leukocyte Count; Neutropenia; Neutrophils; Time Factors; Treatment Outcome | 2003 |
Monotherapy with meropenem versus combination therapy with ceftazidime plus amikacin as empirical therapy for neutropenic fever in children with malignancy.
Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Ceftazidime; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Diarrhea; Drug Therapy, Combination; Female; Fever; Gram-Negative Bacteria; Gram-Positive Cocci; Hospitals, University; Humans; Infant; Male; Meropenem; Neoplasms; Neutropenia; Taiwan; Thienamycins; Treatment Outcome | 2003 |
Meropenem plus amikacin versus piperacillin-tazobactam plus netilmicin as empiric therapy for high-risk febrile neutropenia in children.
Topics: Amikacin; Anti-Bacterial Agents; Drug Therapy, Combination; Fever; Fungi; Gram-Negative Bacteria; Gram-Positive Bacteria; Hematologic Neoplasms; Humans; Infections; Meropenem; Neoplasms; Netilmicin; Neutropenia; Penicillanic Acid; Piperacillin; Tazobactam; Thienamycins | 2004 |
Randomized trial of cefepime monotherapy or cefepime in combination with amikacin as empirical therapy for febrile neutropenia.
Topics: Amikacin; Antineoplastic Agents; Bacteremia; Cefepime; Cephalosporins; Drug Therapy, Combination; Female; Fever; Hematologic Diseases; Humans; Immunocompromised Host; Japan; Leukemia; Male; Neutropenia; Opportunistic Infections | 2004 |
A randomized clinical trial of ceftriaxone and amikacin versus piperacillin tazobactam and amikacin in febrile patients with hematological neoplasia and severe neutropenia.
Topics: Adult; Aged; Amikacin; Anti-Bacterial Agents; Ceftriaxone; Drug Therapy, Combination; Female; Fever; Hematologic Neoplasms; Humans; Male; Middle Aged; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Treatment Outcome | 2005 |
Imipenem/cilastatin versus piperacillin/tazobactam plus amikacin for empirical therapy in febrile neutropenic patients: results of the COSTINE study.
Topics: Adult; Amikacin; Anti-Bacterial Agents; Cilastatin; Cost-Benefit Analysis; Drug Therapy, Combination; Enzyme Inhibitors; Female; Fever; Hematopoietic Stem Cell Transplantation; Humans; Imipenem; Male; Middle Aged; Neoplasms; Neutropenia; Penicillanic Acid; Piperacillin; Prospective Studies; Protease Inhibitors; Spain; Tazobactam; Treatment Outcome | 2005 |
Clinical experience with three combination regimens for the treatment of high-risk febrile neutropenia.
Topics: Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; Ceftazidime; Drug Therapy, Combination; Female; Fever; Humans; Immunocompromised Host; Male; Meropenem; Middle Aged; Neutropenia; Penicillanic Acid; Piperacillin; Prospective Studies; Risk Assessment; Risk Factors; Tazobactam; Thienamycins | 2006 |
Randomized study of cefepime versus ceftazidime plus amikacin in patients with solid tumors treated with high dose chemotherapy (HDC) and peripheral blood stem cell support (PBSCS) with febrile neutropenia.
Topics: Adult; Amikacin; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Cefepime; Ceftazidime; Cephalosporins; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Stem Cell Transplantation; Treatment Outcome | 2006 |
Early hospital discharge versus continued hospitalization in febrile pediatric cancer patients with prolonged neutropenia: A randomized, prospective study.
Topics: Ambulatory Care; Amikacin; Anti-Bacterial Agents; Ceftriaxone; Child; Child, Preschool; Costs and Cost Analysis; Female; Humans; Injections, Intravenous; Length of Stay; Male; Neoplasms; Neutropenia; Patient Discharge; Prospective Studies; Risk Factors; Sepsis; Time Factors | 2007 |
Cefepime plus amikacin as an initial empirical therapy of febrile neutropenia in paediatric cancer patients.
Topics: Adolescent; Adult; Amikacin; Anti-Bacterial Agents; Cefepime; Cephalosporins; Child; Child, Preschool; Drug Therapy, Combination; Female; Fever; Humans; Infant; Male; Neoplasms; Neutropenia; Remission Induction | 2007 |
Clinical outcome of febrile neutropenia in children with cancer using ceftazidime and aminoglycosides.
Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Bacteremia; Ceftazidime; Child; Child, Preschool; Disease-Free Survival; Female; Gentamicins; Guidelines as Topic; Humans; Imipenem; Infant; Male; Neoplasms; Neutropenia; Prospective Studies; Survival Rate | 2007 |
Piperacillin-tazobactam plus amikacin as an initial empirical therapy of febrile neutropenia in paediatric cancer patients.
Topics: Adolescent; Adult; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Male; Neoplasms; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination | 2008 |
Piperacillin/tazobactam plus amikacin versus carbapenem monotherapy as empirical treatment of febrile neutropenia in childhood hematological malignancies.
Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Carbapenems; Child; Child, Preschool; Drug Therapy, Combination; Enzyme Inhibitors; Female; Humans; Leukemia, Myeloid, Acute; Male; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2008 |
Early granulocyte transfusions in high risk febrile neutropenic patients.
Topics: Agranulocytosis; Amikacin; Blood Transfusion; Carbenicillin; Clinical Trials as Topic; Gram-Negative Bacteria; Granulocytes; Humans; Neutropenia; Risk; Sepsis | 1983 |
Combination of amikacin and carbenicillin with or without cefazolin as empirical treatment of febrile neutropenic patients. The International Antimicrobial Therapy Project Group of the European Organization for Research and Treatment of Cancer.
Topics: Agranulocytosis; Amikacin; Bacterial Infections; Carbenicillin; Cefazolin; Clinical Trials as Topic; Drug Therapy, Combination; Fever; Humans; Kanamycin; Kidney Diseases; Neoplasms; Neutropenia | 1983 |
Single-drug versus combination empirical therapy for gram-negative bacillary infections in febrile cancer patients with and without granulocytopenia.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Anti-Bacterial Agents; Cefoperazone; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Pseudomonas Infections; Sepsis; Staphylococcal Infections | 1984 |
Combination of amikacin and either ampicillin or cephalotin as initial treatment of febrile neutropenic patients.
Topics: Adult; Aged; Agranulocytosis; Amikacin; Ampicillin; Bacterial Infections; Cephalothin; Clinical Trials as Topic; Drug Combinations; Female; Fever; Hematologic Diseases; Humans; Kanamycin; Male; Middle Aged; Neutropenia; Prospective Studies; Random Allocation | 1982 |
Aminoglycosides in the treatment of bacteraemic infections in the immuno-comprised host.
Topics: Agranulocytosis; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Drug Therapy, Combination; Gentamicins; Humans; Netilmicin; Neutropenia; Sepsis | 1981 |
Randomized trial comparing oral ciprofloxacin plus penicillin V with amikacin plus carbenicillin or ceftazidime for empirical treatment of febrile neutropenic cancer patients.
Topics: Administration, Oral; Adult; Amikacin; Carbenicillin; Ceftazidime; Ciprofloxacin; Costs and Cost Analysis; Drug Therapy, Combination; Female; Fever of Unknown Origin; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Penicillin V; Prospective Studies | 1995 |
Effects of teicoplanin and those of vancomycin in initial empirical antibiotic regimen for febrile, neutropenic patients with hematologic malignancies. Gimema Infection Program.
Topics: Adolescent; Adult; Aged; Amikacin; Amphotericin B; Bacteremia; Ceftazidime; Drug Therapy, Combination; Female; Fever; Gram-Positive Bacterial Infections; Hematologic Diseases; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Prospective Studies; Teicoplanin; Vancomycin | 1994 |
[Piperacilline/tazobactam combination+amikacin versus ceftazidime+amikacin in patients with neutropenia and fever. An open multicenter study. Groupe d'étude des Aplasies Fébriles].
Topics: Adult; Aged; Amikacin; beta-Lactamase Inhibitors; Ceftazidime; Drug Therapy, Combination; Fever; Humans; Middle Aged; Neutropenia; Penicillanic Acid; Piperacillin; Tazobactam | 1995 |
Empirical antibiotic therapy in febrile neutropenic patients with single-daily dose amikacin plus ceftriaxone.
Topics: Adolescent; Adult; Aged; Amikacin; Ceftriaxone; Drug Therapy, Combination; Female; Fever of Unknown Origin; Humans; Male; Middle Aged; Neutropenia; Sepsis | 1993 |
Amikacin and ceftazidime as empirical antibiotic therapy in severely neutropenic patients: analysis of prognostic factors.
Topics: Adult; Amikacin; Antifungal Agents; Bacterial Infections; Cause of Death; Ceftazidime; Drug Combinations; Female; Humans; Length of Stay; Leukemia; Lymphoma; Male; Middle Aged; Mycoses; Neutropenia; Pneumonia; Prognosis; Prospective Studies; Remission Induction; Time Factors; Treatment Outcome | 1994 |
A randomized prospective study of imipenem-cilastatin with or without amikacin as an empirical antibiotic treatment for febrile neutropenic patients.
Topics: Adult; Aged; Amikacin; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Cilastatin; Drug Therapy, Combination; Female; Fever; Humans; Imipenem; Logistic Models; Male; Middle Aged; Neutropenia; Prospective Studies; Treatment Outcome | 1994 |
Should vancomycin be used empirically in febrile patients with prolonged and profound neutropenia? Results of a randomized trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Bacterial Infections; Ceftazidime; Child; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Neutropenia; Vancomycin | 1993 |
Piperacillin/tazobactam/amikacin versus piperacillin/amikacin/teicoplanin in the empirical treatment of neutropenic patients.
Topics: Adolescent; Adult; Aged; Amikacin; Bacteremia; Bacteria; Bacterial Infections; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Neutropenia; Penicillanic Acid; Piperacillin; Prospective Studies; Tazobactam; Teicoplanin | 1993 |
[Imipenem/cilastatin versus ceftazidime-amikacin in the treatment of febrile neutropenic patients].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Chi-Square Distribution; Cilastatin; Drug Therapy, Combination; Female; Fever; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Infections; Male; Middle Aged; Neutropenia; Prognosis; Prospective Studies; Protease Inhibitors; Thienamycins | 1995 |
Isepamicin once daily plus ceftriaxone versus amikacin plus ceftriaxone in febrile neutropenic patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Bone Marrow Transplantation; Ceftriaxone; Drug Administration Schedule; Drug Therapy, Combination; Female; Fever; Gentamicins; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Superinfection | 1995 |
Population pharmacokinetic study of teicoplanin in severely neutropenic patients.
Topics: Adult; Aged; Amikacin; Drug Administration Schedule; Drug Therapy, Combination; Female; Fever; Humans; Leukemia; Lymphoma; Male; Middle Aged; Multiple Myeloma; Neutropenia; Piperacillin; Staphylococcal Infections; Teicoplanin | 1996 |
Trimethoprim-sulfamethoxazole plus amikacin versus ceftazidime monotherapy as empirical treatment in patients with neutropenia and fever.
Topics: Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; Bacteremia; Blood; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Fever; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Male; Middle Aged; Neutropenia; Trimethoprim, Sulfamethoxazole Drug Combination | 1996 |
Cefepime/amikacin versus ceftazidime/amikacin as empirical therapy for febrile episodes in neutropenic patients: a comparative study. The French Cefepime Study Group.
Topics: Amikacin; Anti-Bacterial Agents; Bacteremia; Bacterial Infections; Cefepime; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Fever; Gastrointestinal Diseases; Gram-Negative Bacteria; Gram-Positive Bacteria; Hematologic Neoplasms; Humans; Male; Neutropenia; Skin Diseases, Bacterial; Soft Tissue Infections; Urinary Tract Infections | 1997 |
Once daily ceftriaxone plus amikacin vs. three times daily ceftazidime plus amikacin for treatment of febrile neutropenic children with cancer. Writing Committee for the International Collaboration on Antimicrobial Treatment of Febrile Neutropenia in Chil
Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Cost-Benefit Analysis; Drug Therapy, Combination; Female; Fever; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Infant; Leukemia; Lymphoma; Male; Microbial Sensitivity Tests; Neoplasms; Neutropenia | 1997 |
Meropenem monotherapy versus combination therapy with ceftazidime and amikacin for empirical treatment of febrile neutropenic patients.
Topics: Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; Bacteremia; Bacterial Infections; Ceftazidime; Cephalosporins; Drug Therapy, Combination; Female; Fever; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Male; Meropenem; Middle Aged; Neutropenia; Thienamycins | 1998 |
Population pharmacokinetic study of amikacin administered once or twice daily to febrile, severely neutropenic adults.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Creatinine; Enzyme-Linked Immunosorbent Assay; Female; Fever; Humans; Kidney Diseases; Male; Middle Aged; Models, Biological; Neutropenia; Population | 1998 |
Neutropenic infections: a review of the French Febrile Aplasia Study Group trials in 608 febrile neutropenic patients.
Topics: Amikacin; Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Ciprofloxacin; Drug Therapy, Combination; Fever; Hematologic Neoplasms; Humans; Multivariate Analysis; Neutropenia; Opportunistic Infections; Penicillanic Acid; Piperacillin; Tazobactam; Vancomycin | 1998 |
Monotherapy with piperacillin/tazobactam versus combination therapy with ceftazidime plus amikacin as an empiric therapy for fever in neutropenic cancer patients.
Topics: Adolescent; Adult; Aged; Amikacin; Analysis of Variance; Anti-Bacterial Agents; Ceftazidime; Chi-Square Distribution; Drug Therapy, Combination; Enzyme Inhibitors; Female; Fever; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Penicillanic Acid; Piperacillin; Prognosis; Prospective Studies; Tazobactam; Treatment Failure; Treatment Outcome | 1998 |
Decreasing antibiotic resistance of Enterobacteriaceae by introducing a new antibiotic combination therapy for neutropenic fever patients.
Topics: Adult; Amikacin; Cefepime; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Drug Therapy, Combination; Enterobacteriaceae; Enterobacteriaceae Infections; Fever; Hematologic Diseases; Humans; Microbial Sensitivity Tests; Neutropenia; Teicoplanin; Vancomycin | 1998 |
Outpatient therapy with oral ofloxacin for patients with low risk neutropenia and fever: a prospective, randomized clinical trial.
Topics: Administration, Oral; Adult; Aged; Ambulatory Care; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Ceftazidime; Cephalosporins; Drug Therapy, Combination; Female; Fever; Hospitalization; Humans; Injections, Intravenous; Male; Middle Aged; Neoplasms; Neutropenia; Ofloxacin; Prospective Studies; Treatment Outcome | 1999 |
Randomized prospective study comparing cost-effectiveness of teicoplanin and vancomycin as second-line empiric therapy for infection in neutropenic patients.
Topics: Amikacin; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; Blood Chemical Analysis; Cost-Benefit Analysis; Drug Costs; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Hematologic Neoplasms; Humans; Male; Middle Aged; Neutropenia; Penicillanic Acid; Piperacillin; Prospective Studies; Safety; Tazobactam; Teicoplanin; Treatment Failure; Vancomycin | 1999 |
Imipenem-cilastatin versus sulbactam-cefoperazone plus amikacin in the initial treatment of febrile neutropenic cancer patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Bacteremia; Cefoperazone; Cilastatin; Drug Therapy, Combination; Female; Fever; Humans; Imipenem; Male; Middle Aged; Neoplasms; Neutropenia; Prospective Studies; Sulbactam | 1999 |
An open evaluation of triple antibiotic therapy including vancomycin for febrile bone marrow transplant recipients with severe neutropenia.
Topics: Adolescent; Adult; Amikacin; Bacterial Infections; Bone Marrow Transplantation; Ceftazidime; Child; Cross Infection; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Neutropenia; Prospective Studies; Treatment Outcome; Vancomycin | 1999 |
Comparison of meropenem with amikacin plus ceftazidime in the empirical treatment of febrile neutropenia: a prospective randomised multicentre trial in patients without previous prophylactic antibiotics. Meropenem Study Group of Turkey.
Topics: Adult; Amikacin; Antibiotic Prophylaxis; Ceftazidime; Drug Therapy, Combination; Female; Fever; Humans; Male; Meropenem; Middle Aged; Neutropenia; Prospective Studies; Thienamycins; Treatment Outcome | 1999 |
Oral administration of cefixime to lower risk febrile neutropenic children with cancer.
Topics: Administration, Oral; Adolescent; Amikacin; Anti-Bacterial Agents; Antineoplastic Agents; Cefixime; Cephalosporins; Child; Child, Preschool; Female; Fever; Humans; Infusions, Intravenous; Male; Neoplasms; Neutropenia; Risk Factors | 2000 |
Management of fever in neutropenic patients with acute leukemia: current role of ceftazidime plus amikacin as empiric therapy.
Topics: Acute Disease; Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Drug Therapy, Combination; Female; Fever; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Leukemia, Myeloid; Male; Middle Aged; Neutropenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Treatment Outcome | 2000 |
Single-daily ceftriaxone plus amikacin versus thrice-daily ceftazidime plus amikacin as empirical treatment of febrile neutropenia in children with cancer.
Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Bacteremia; Ceftazidime; Ceftriaxone; Child; Child, Preschool; Cost-Benefit Analysis; Drug Therapy, Combination; Female; Humans; Logistic Models; Male; Multivariate Analysis; Neoplasms; Neutropenia; Prospective Studies; Statistics, Nonparametric | 2001 |
Oral ciprofloxacin in the management of children with cancer with lower risk febrile neutropenia.
Topics: Administration, Oral; Adolescent; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Antineoplastic Agents; Cefixime; Cephalosporins; Child; Child, Preschool; Ciprofloxacin; Female; Fever; Fever of Unknown Origin; Humans; Infant; Infusions, Intravenous; Male; Neoplasms; Neutropenia; Risk Factors; Treatment Outcome | 2001 |
Cost-effectiveness of cefepime + netilmicin or ceftazidime + amikacin or meropenem monotherapy in febrile neutropenic children with malignancy in Turkey.
Topics: Adolescent; Adult; Amikacin; Cefepime; Cephalosporins; Child; Child, Preschool; Cost-Benefit Analysis; Drug Therapy, Combination; Female; Fever; Humans; Infant; Male; Meropenem; Neoplasms; Netilmicin; Neutropenia; Prospective Studies; Thienamycins; Turkey | 2001 |
A multicenter, double-blind, placebo-controlled trial comparing piperacillin-tazobactam with and without amikacin as empiric therapy for febrile neutropenia.
Topics: Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Double-Blind Method; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Treatment Outcome | 2001 |
Comparison of isepamicin with amikacin for the empirical treatment of febrile neutropenic children with malignancies.
Topics: Amikacin; Anti-Bacterial Agents; Bacterial Infections; Child; Child, Preschool; Drug-Related Side Effects and Adverse Reactions; Fever; Gentamicins; Humans; Male; Neoplasms; Neutropenia; Random Allocation | 2001 |
Comparison of cefepime and ceftazidime in combination with amikacin in the empirical treatment of high-risk patients with febrile neutropenia: a prospective, randomized, multicenter study.
Topics: Adolescent; Adult; Amikacin; Anti-Bacterial Agents; Cefepime; Ceftazidime; Cephalosporins; Drug Therapy, Combination; Fever; Humans; Leukemia; Lymphoma, Non-Hodgkin; Neutropenia; Prospective Studies; Risk Factors; Treatment Outcome | 2001 |
Clinafloxacin monotherapy (CI-960) versus ceftazidime plus amikacin for empirical treatment of febrile neutropenic cancer patients.
Topics: Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Ceftazidime; Cephalosporins; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Fever; Fluoroquinolones; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Teicoplanin; Treatment Outcome; Vancomycin | 2002 |
Cefepime plus amikacin versus piperacillin-tazobactam plus amikacin for initial antibiotic therapy in haematology patients with febrile neutropenia: results of an open, randomized, multicentre trial.
Topics: Adult; Amikacin; Anti-Bacterial Agents; Cefepime; Cephalosporins; Drug Therapy, Combination; Female; Fever; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Male; Neutropenia; Penicillanic Acid; Piperacillin; Tazobactam; Treatment Outcome | 2002 |
A randomized comparative trial of three aminoglycosides--comparison of continuous infusions of gentamicin, amikacin and sisomicin combined with carbenicillin in the treatment of infections in neutropenic patients with malignancies.
Topics: Adolescent; Adult; Aged; Amikacin; Bacterial Infections; Carbenicillin; Drug Therapy, Combination; Female; Gentamicins; Humans; Infusions, Parenteral; Kanamycin; Kidney; Male; Middle Aged; Neoplasms; Neutropenia; Uremia | 1979 |
Randomised comparison of oral ofloxacin alone with combination of parenteral antibiotics in neutropenic febrile patients.
Topics: Administration, Oral; Adult; Amikacin; Anti-Bacterial Agents; Carbenicillin; Cloxacillin; Drug Therapy, Combination; Female; Fever; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Male; Neutropenia; Ofloxacin; Piperacillin; Prospective Studies | 1992 |
Piperacillin plus amikacin vs. piperacillin plus amikacin plus teicoplanin for empirical treatment of febrile episodes in neutropenic patients receiving quinolone prophylaxis.
Topics: 4-Quinolones; Amikacin; Anti-Infective Agents; Bacteremia; Drug Therapy, Combination; Female; Fever; Glycopeptides; Gram-Positive Bacteria; Humans; Male; Neutropenia; Piperacillin; Prospective Studies; Teicoplanin | 1992 |
Comparison of two antibiotic regimens (piperacillin plus amikacin versus ceftazidime plus amikacin) as empiric therapy for febrile neutropenic patients with cancer.
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Bacterial Infections; Ceftazidime; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Piperacillin; Vancomycin | 1992 |
[Evaluation of three types of empirical antibiotherapy in patients with febrile neutropenia: imipenem-cilastatin versus ceftazidime-vancomycin versus ticarcillin-amikacin-vancomycin].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Bacterial Infections; Ceftazidime; Cilastatin; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Middle Aged; Neutropenia; Prospective Studies; Ticarcillin; Vancomycin | 1992 |
Ototoxicity associated with a once daily dose amikacin regimen in febrile neutropenic patients.
Topics: Amikacin; Drug Administration Schedule; Fever; Hearing Loss, Sensorineural; Humans; Neutropenia; Pilot Projects | 1992 |
Trimethoprim-sulfamethoxazole plus amikacin as first-line therapy and imipenem/cilastatin as second empirical therapy in febrile neutropenic patients with hematological disorders.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Bacterial Infections; Bone Marrow Transplantation; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Therapy, Combination; Female; Fever; Hematologic Diseases; Humans; Imipenem; Leukemia; Lymphoma; Male; Middle Aged; Neutropenia; Pneumocystis Infections; Sepsis; Trimethoprim, Sulfamethoxazole Drug Combination | 1992 |
A comparison of imipenem to ceftazidime with or without amikacin as empiric therapy in febrile neutropenic patients.
Topics: Adolescent; Adult; Aged; Amikacin; Bacterial Infections; Ceftazidime; Drug Therapy, Combination; Fever; Humans; Imipenem; Middle Aged; Neoplasms; Neutropenia; Prognosis; Superinfection | 1992 |
The efficacy of mezlocillin-amikacin combination in febrile neutropenic children with oncologic disease.
Topics: Adolescent; Amikacin; Child; Child, Preschool; Drug Therapy, Combination; Female; Fever; Haemophilus Infections; Humans; Infant; Male; Mezlocillin; Neisseriaceae Infections; Neoplasms; Neutropenia; Staphylococcal Infections; Streptococcal Infections | 1991 |
Randomized clinical trial comparing ceftriaxone/amikacin versus ceftazidime/amikacin as initial therapy of febrile episodes in neutropenic patients.
Topics: Adolescent; Adult; Aged; Amikacin; Bacterial Infections; Ceftazidime; Ceftriaxone; Drug Administration Schedule; Drug Therapy, Combination; Female; Fever; Humans; Leukemia; Male; Middle Aged; Neutropenia | 1991 |
Teicoplanin in the treatment of gram-positive bacteraemia in neutropenic patients.
Topics: Adolescent; Adult; Amikacin; Anti-Bacterial Agents; Child; Child, Preschool; Drug Therapy, Combination; Fever; Glycopeptides; Gram-Positive Bacteria; Humans; Middle Aged; Neutropenia; Piperacillin; Prospective Studies; Sepsis; Teicoplanin | 1990 |
Treatment of fever and neutropenia with antibiotics versus antibiotics plus intravenous gammaglobulin in childhood leukemia.
Topics: Agranulocytosis; Amikacin; Antineoplastic Agents; Cefotaxime; Child; Drug Therapy, Combination; Fever; Humans; Immunoglobulin G; Immunoglobulins, Intravenous; Infection Control; Leukemia, Myeloid, Acute; Neutropenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1989 |
Vancomycin does not enhance amikacin-induced tubular nephrotoxicity in children.
Topics: Adolescent; Amikacin; Animals; Child; Child, Preschool; Clinical Trials as Topic; Double-Blind Method; Drug Synergism; Drug Therapy, Combination; Female; Fever; Humans; Kidney Diseases; Kidney Tubules; Male; Neutropenia; Proteinuria; Random Allocation; Rats; Ticarcillin; Vancomycin | 1989 |
Multicenter, randomized trial of ciprofloxacin plus azlocillin versus ceftazidime plus amikacin for empiric treatment of febrile neutropenic patients.
Topics: Adult; Aged; Aged, 80 and over; Agranulocytosis; Amikacin; Azlocillin; Bacterial Infections; Ceftazidime; Ciprofloxacin; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Multicenter Studies as Topic; Neutropenia; Random Allocation | 1989 |
A randomised trial of empirical antibiotic therapy in febrile neutropenic patients with hematological disorders: ceftazidime versus azlocillin plus amikacin.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Agranulocytosis; Amikacin; Azlocillin; Bacterial Infections; Ceftazidime; Drug Therapy, Combination; Female; Fever; Floxacillin; Hematologic Diseases; Humans; Male; Middle Aged; Neutropenia; Randomized Controlled Trials as Topic; Remission Induction; Therapeutic Equivalency | 1989 |
Evaluation of azlocillin-amikacin combination for empirical therapy of infection in febrile neutropenic patients.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Azlocillin; Bacterial Infections; Child; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Neutropenia | 1989 |
Imipenem/cilastatin versus piperacillin plus amikacin as empiric therapy in the treatment of febrile episodes in neutropenic patients with haematologic malignancies.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Cilastatin; Female; Humans; Imipenem; Leukemia; Lymphoma; Male; Middle Aged; Neutropenia; Piperacillin; Prospective Studies; Random Allocation | 1989 |
[Treatment of infectious outbreaks in neutropenic patients with a piperacillin and amikacin combination].
Topics: Agranulocytosis; Amikacin; Bacterial Infections; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Neutropenia; Pilot Projects; Piperacillin | 1986 |
[Prospective and comparative study of 2 antibiotic therapy protocols in 66 febrile neutropenic patients. Ceftazidime-vancomycin versus ticarcillin-vancomycin-amikacin].
Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Bacterial Infections; Ceftazidime; Drug Evaluation; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Neutropenia; Penicillins; Prospective Studies; Ticarcillin; Vancomycin | 1988 |
[Antibiotic therapy protocol using ceftazidime 3g/day alone or in combination with vancomycin or amikacin. In febrile episodes in neutropenic patients].
Topics: Agranulocytosis; Amikacin; Bacterial Infections; Ceftazidime; Clinical Trials as Topic; Drug Therapy, Combination; Fever; Humans; Neutropenia; Random Allocation; Vancomycin | 1988 |
Vancomycin, ticarcillin, and amikacin compared with ticarcillin-clavulanate and amikacin in the empirical treatment of febrile, neutropenic children with cancer.
Topics: Adolescent; Adult; Agranulocytosis; Amikacin; Bacterial Infections; Child; Child, Preschool; Clavulanic Acids; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Female; Fever; Humans; Infant; Male; Neoplasms; Neutropenia; Penicillins; Random Allocation; Ticarcillin; Vancomycin | 1988 |
Treatment of febrile episodes in neutropenic leukemic patients with the antibiotic combinations piperacillin or ceftazidime plus amikacin: results of a randomized study.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Bacterial Infections; Ceftazidime; Child; Drug Therapy, Combination; Female; Fever; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Neutropenia; Piperacillin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Random Allocation | 1988 |
Piperacillin plus amikacin versus cefotaxime plus amikacin in neutropenic and feverish patients with malignant hemopathies.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Agranulocytosis; Amikacin; Bacterial Infections; Cefotaxime; Drug Therapy, Combination; Female; Fever; Humans; Leukemia; Lymphoma; Male; Middle Aged; Neutropenia; Piperacillin; Prospective Studies | 1988 |
Imipenem/cilastatin versus amikacin plus piperacillin in the treatment of infections in neutropenic patients: a prospective, randomized multi-clinic study.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Cilastatin; Cilastatin, Imipenem Drug Combination; Clinical Trials as Topic; Cyclopropanes; Drug Combinations; Drug Resistance, Microbial; Female; Humans; Imipenem; Male; Middle Aged; Neutropenia; Penicillin Resistance; Piperacillin; Prospective Studies; Random Allocation; Thienamycins | 1987 |
European experience of timentin in combination with aminoglycosides as empirical treatment in febrile neutropenic patients.
Topics: Adult; Agranulocytosis; Amikacin; Bacterial Infections; beta-Lactamase Inhibitors; Child; Clavulanic Acids; Clinical Trials as Topic; Drug Therapy, Combination; Fever; Fever of Unknown Origin; Humans; Netilmicin; Neutropenia; Penicillins; Retrospective Studies; Sepsis; Ticarcillin; Tobramycin | 1987 |
Review of amikacin usage in the EORTC trials.
Topics: Agranulocytosis; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Clinical Trials as Topic; Drug Therapy, Combination; Fever; Gentamicins; Humans; International Cooperation; Kanamycin; Kidney Diseases; Lactams; Neoplasms; Neutropenia | 1985 |
74 other study(ies) available for amikacin and Neutropenia
| Article | Year |
|---|---|
Topics: Amikacin; Animals; Anti-Bacterial Agents; Mice; Microbial Sensitivity Tests; Mycobacterium Infections, Nontuberculous; Mycobacterium tuberculosis; Neutropenia; Nontuberculous Mycobacteria | 2022 |
Clinical characteristics and outcomes of Pseudomonas aeruginosa bacteremia in febrile neutropenic children and adolescents with the impact of antibiotic resistance: a retrospective study.
Topics: Adolescent; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Carbapenems; Cephalosporins; Child; Child, Preschool; Drug Resistance, Multiple, Bacterial; Female; Fever; Fluoroquinolones; Humans; Male; Meropenem; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Thienamycins | 2017 |
Biological evaluation of diphenyleneiodonium chloride (DPIC) as a potential drug candidate for treatment of non-tuberculous mycobacterial infections.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Bacterial Load; Chlorocebus aethiops; Disease Models, Animal; Drug Discovery; Kinetics; Meropenem; Mice; Microbial Sensitivity Tests; Mycobacterium Infections, Nontuberculous; Neutropenia; Nontuberculous Mycobacteria; Onium Compounds; Small Molecule Libraries; Thienamycins; Vero Cells | 2017 |
In vivo efficacy of apramycin in murine infection models.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Female; Interferon-gamma; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Knockout; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nebramycin; Neutropenia; Staphylococcal Infections; Tuberculosis, Pulmonary | 2014 |
Pharmacodynamics of nine generic products of amikacin compared with the innovator in the neutropenic mouse thigh infection model.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Disease Models, Animal; Escherichia coli Infections; Mice; Neutropenia | 2015 |
Antibiotic treatment of Mycobacterium abscessus lung disease: a retrospective analysis of 65 patients.
Topics: Adult; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Cefoxitin; Chemical and Drug Induced Liver Injury; Ciprofloxacin; Clarithromycin; Doxycycline; Drug Therapy, Combination; Female; Humans; Liver; Lung; Lung Diseases; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Neutropenia; Nontuberculous Mycobacteria; Retrospective Studies; Sputum; Thrombocytopenia; Tomography, X-Ray Computed; Treatment Outcome | 2009 |
Cefepime and mortality.
Topics: Amikacin; Anti-Bacterial Agents; Cefepime; Cephalosporins; Drug Resistance, Bacterial; Drug Therapy, Combination; Fever of Unknown Origin; Humans; Neutropenia | 2009 |
[Cefepime versus piperacillin/tazobactam with or without amikacin in the treatment of febrile hematological and oncological neutropenic patients in an internal medicine ward].
Topics: Adult; Aged; Amikacin; Anti-Bacterial Agents; Cefepime; Cephalosporins; Drug Therapy, Combination; Female; Fever; Hematologic Neoplasms; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Risk Factors; Treatment Outcome | 2010 |
Empirical therapy with ceftazidime combined with levofloxacin or once-daily amikacin for febrile neutropenia in patients with neoplasia: a prospective comparative study.
Topics: Aged; Amikacin; Anti-Bacterial Agents; Ceftazidime; Drug Therapy, Combination; Female; Fever of Unknown Origin; Humans; Kidney Diseases; Levofloxacin; Male; Middle Aged; Neoplasms; Neutropenia; Ofloxacin; Prospective Studies; Survival Analysis; Treatment Outcome | 2012 |
Therapeutic drug monitoring of aminoglycosides in acute myeloid leukaemia patients.
Topics: Adult; Aged; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Drug Administration Schedule; Drug Monitoring; Drug Therapy, Combination; Female; Gentamicins; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Neutropenia; Practice Guidelines as Topic; Treatment Outcome; Young Adult | 2012 |
Facial ecthyma gangrenosum in 2 preterm neonates.
Topics: Amikacin; Facial Dermatoses; Fatal Outcome; Female; Gangrene; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Meropenem; Necrosis; Neutropenia; Pseudomonas aeruginosa; Pseudomonas Infections; Sepsis; Skin Diseases, Bacterial; Skin Ulcer; Thienamycins | 2012 |
[Microbiological characteristics of pathogens causing bacteremia among hospitalized pediatric oncology patients with fever and neutropenia].
Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Bacteremia; Candida; Child; Child, Hospitalized; Child, Preschool; Clinical Protocols; Drug Resistance, Bacterial; Female; Fever; Gram-Negative Bacteria; Gram-Positive Bacteria; Hematologic Neoplasms; Humans; Infant; Israel; Male; Microbial Sensitivity Tests; Neutropenia; Piperacillin; Prevalence; Treatment Outcome | 2012 |
Elderly haematological patients with chemotherapy-induced febrile neutropenia have similar rates of infection and outcome to younger adults: a prospective study of risk-adapted therapy.
Topics: Acute Disease; Adult; Age Factors; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; Ceftazidime; Cephalosporins; Chi-Square Distribution; Hematologic Neoplasms; Humans; Leukemia, Myeloid; Lymphoma, Non-Hodgkin; Middle Aged; Neutropenia; Prospective Studies; Risk Factors; Treatment Outcome | 2003 |
[Cefepime-amikacin combination in febrile neutropenic children with malignant hemopathy or tumor].
Topics: Adolescent; Adult; Amikacin; Anti-Bacterial Agents; Antineoplastic Agents; Bacterial Infections; Cefepime; Cephalosporins; Child; Child, Preschool; Drug Therapy, Combination; Fever; Hematologic Neoplasms; Humans; Infant; Neoplasms; Neutropenia; Patient Selection; Prognosis; Retrospective Studies; Time Factors; Treatment Outcome | 2003 |
Monotherapy versus dual therapy based on risk categorization of febrile neutropenic patients.
Topics: Amikacin; Anti-Bacterial Agents; Cefepime; Cephalosporins; Drug Therapy, Combination; Fever; Hematologic Diseases; Humans; Immunocompromised Host; Neutropenia; Opportunistic Infections; Risk Assessment; Sepsis | 2004 |
Emerging bacterial resistance patterns in febrile neutropenic patients: experience at a tertiary care hospital in Pakistan.
Topics: Amikacin; Anti-Bacterial Agents; Bacterial Infections; Cloxacillin; Drug Resistance, Bacterial; Fever; Gram-Negative Bacteria; Gram-Positive Bacteria; Hematologic Neoplasms; Hospitals, University; Humans; Imipenem; Leukemia; Microbial Sensitivity Tests; Neutropenia; Pakistan; Retrospective Studies; Vancomycin | 2004 |
[Management of febrile neutropenic patients].
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Drug Therapy, Combination; Fever; Glycopeptides; Granulocyte Colony-Stimulating Factor; Hematologic Neoplasms; Humans; Immunoglobulin G; Infections; Neutropenia | 2006 |
Central line-related bacteraemia due to Roseomonas mucosa in a neutropenic patient with acute myeloid leukaemia in Piraeus, Greece.
Topics: Acute Disease; Adult; Amikacin; Anti-Bacterial Agents; Antimetabolites, Antineoplastic; Antineoplastic Agents; Bacteremia; Base Sequence; Catheterization, Central Venous; Cytarabine; Humans; Leukemia, Myeloid; Male; Methylobacteriaceae; Molecular Sequence Data; Neutropenia; Penicillanic Acid; Phylogeny; Piperacillin; Piperacillin, Tazobactam Drug Combination; RNA, Bacterial; RNA, Ribosomal, 16S; Vidarabine | 2006 |
Are we finally ready for outpatient management of febrile neutropenia?
Topics: Ambulatory Care; Amikacin; Anti-Bacterial Agents; Ceftriaxone; Child; Child, Preschool; Costs and Cost Analysis; Female; Humans; Injections, Intravenous; Length of Stay; Male; Monitoring, Physiologic; Neoplasms; Neutropenia; Patient Discharge; Prospective Studies; Risk Factors; Safety Management; Sepsis; Time Factors | 2007 |
Comparison of azlocillin, ceftizoxime, cefoxitin, and amikacin alone and in combination against Pseudomonas aeruginosa in a neutropenic-site rabbit model.
Topics: Agranulocytosis; Amikacin; Animals; Anti-Bacterial Agents; Azlocillin; Cefotaxime; Cefoxitin; Ceftizoxime; Disease Models, Animal; Drug Combinations; Female; Hydrogen-Ion Concentration; Kanamycin; Microbial Sensitivity Tests; Neutropenia; Penicillins; Protein Binding; Pseudomonas Infections; Rabbits | 1984 |
Disseminated disease due to Mycobacterium chelonei treated with amikacin and cefoxitin. Absence of killing with either agent and possible role of granulocytes in clinical response.
Topics: Adult; Amikacin; Cefoxitin; Drug Resistance, Microbial; Granulocytes; Humans; Kanamycin; Lymphoma; Male; Mycobacterium; Mycobacterium Infections; Mycobacterium Infections, Nontuberculous; Neutropenia; Nontuberculous Mycobacteria; Skin Diseases, Infectious | 1984 |
Etiology of infections in neutropenic patients with acute leukemia. Results of two antibiotic combinations.
Topics: Acute Disease; Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Anti-Bacterial Agents; Cephalothin; Cephapirin; Child; Child, Preschool; Drug Therapy, Combination; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Middle Aged; Neutropenia; Random Allocation; Sepsis; Tobramycin | 1981 |
Therapy of Klebsiella pneumoniae septicaemia in neutropenic rats.
Topics: Agranulocytosis; Amikacin; Animals; Anti-Bacterial Agents; Female; Gentamicins; Klebsiella Infections; Klebsiella pneumoniae; Neutropenia; Rats; Rats, Inbred Strains; Sepsis; Sisomicin; Tobramycin | 1982 |
Treatment and prevention of bacterial infections during cytostatic chemotherapy.
Topics: Agranulocytosis; Amikacin; Bacterial Infections; Blood Transfusion; Carbenicillin; Cephalosporins; Drug Synergism; Granulocytes; Humans; Kanamycin; Neutropenia | 1981 |
Efficacy of amikacin and ticarcillin as empiric therapy in febrile neutropenic children with cancer.
Topics: Adolescent; Agranulocytosis; Amikacin; Bacterial Infections; Child; Child, Preschool; Evaluation Studies as Topic; Female; Humans; Infant; Kanamycin; Male; Neoplasms; Neutropenia; Penicillins; Ticarcillin | 1981 |
Prediction of amikacin dose requirements in neutropenic patients with haematological disease.
Topics: Adolescent; Adult; Amikacin; Bayes Theorem; Female; Hematologic Diseases; Humans; Male; Middle Aged; Neutropenia | 1993 |
Ceftazidime and amikacin as empirical treatment of febrile episodes in neutropenic patients.
Topics: Adolescent; Adult; Aged; Amikacin; Bacteremia; Ceftazidime; Child; Child, Preschool; Fever; Humans; Leukemia; Middle Aged; Neutropenia; Remission Induction | 1994 |
Ceftriaxone versus ceftazidime plus aminoglycoside therapy for infections in patients with neutropenia after cytotoxic chemotherapy. Short communication.
Topics: Amikacin; Antineoplastic Agents; Bacterial Infections; Candidiasis; Catheterization, Central Venous; Catheterization, Peripheral; Ceftazidime; Ceftriaxone; Drug Therapy, Combination; Hearing; Humans; Kidney; Leukemia; Lymphoma; Neutropenia; Retrospective Studies | 1993 |
Salicylate potentiates amikacin therapy in rodent models of Klebsiella pneumoniae infection.
Topics: Amikacin; Animals; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Klebsiella Infections; Klebsiella pneumoniae; Mice; Neutropenia; Pneumonia; Rats; Rats, Sprague-Dawley; Sodium Salicylate; Survival Analysis | 1993 |
Disseminating infection with Scytalidium dimidiatum in a granulocytopenic child.
Topics: Adolescent; Amikacin; Amphotericin B; Ceftazidime; Drug Therapy, Combination; Humans; Immunocompromised Host; Lymphoma, B-Cell; Male; Mitosporic Fungi; Morocco; Mycoses; Netherlands; Neutropenia; Vancomycin | 1993 |
Hypermagnesiuria and hypercalciuria in childhood leukemia: an effect of amikacin therapy.
Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Antineoplastic Agents; Calcium; Child; Child, Preschool; Female; Humans; Kidney Tubules, Proximal; Magnesium; Male; Neutropenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prospective Studies | 1996 |
[Assessment of pharmacokinetic parameters of amikacin in a group of neutropenic patients in onco-hematology].
Topics: Adult; Aged; Amikacin; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Female; France; Hospital Units; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasms; Neutropenia; Retrospective Studies | 1996 |
[Clinical, pharmacokinetic and therapeutic study of amikacin with single daily dose and in combination in neutropenic children with fever].
Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Child; Child, Preschool; Drug Therapy, Combination; Fever; Humans; Infant; Neutropenia; Penicillins; Piperacillin; Vancomycin | 1996 |
Parvovirus B19 associated neutropenia. Treatment with Rh G-CSF.
Topics: Adenocarcinoma; Adult; Amikacin; Colonic Neoplasms; DNA, Viral; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Injections, Intravenous; Liver Neoplasms; Neutropenia; Parvoviridae Infections; Parvovirus B19, Human; Pefloxacin; Penicillanic Acid; Piperacillin; Recombinant Proteins; Tazobactam | 1997 |
Comparison of amikacin dosing regimens in neutropenic guinea pigs with Escherichia coli infection.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Escherichia coli Infections; Female; Guinea Pigs; Half-Life; Leukocyte Count; Male; Metabolic Clearance Rate; Neutropenia; Neutrophils; Reference Values | 1998 |
Empirical antimicrobial therapy in pediatric patients with neutropenia and fever. Risk factors for treatment failure.
Topics: Amikacin; Anti-Bacterial Agents; Carbenicillin; Ceftazidime; Child; Drug Therapy, Combination; Fever; Humans; Neutropenia; Risk Factors; Treatment Failure | 1998 |
Aetiology, cost of antimicrobial therapy and outcome in neutropenic patients who developed bacteraemia during antimicrobial prophylaxis: a case-control study.
Topics: Amikacin; Amphotericin B; Antibiotic Prophylaxis; Bacteremia; Bacterial Infections; Case-Control Studies; Catheters, Indwelling; Ceftazidime; Drug Therapy, Combination; Enterococcus; Female; Fluconazole; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Male; Neoplasms; Neutropenia; Ofloxacin; Retrospective Studies; Streptococcal Infections; Treatment Outcome; Vancomycin; Xanthomonas | 1998 |
Outpatient management of acute promyelocytic leukemia after consolidation chemotherapy.
Topics: Adult; Aged; Ambulatory Care; Amikacin; Anemia; Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; Ceftriaxone; Cerebral Hemorrhage; Cross Infection; Drug Therapy, Combination; Emergency Service, Hospital; Female; Fever; Hospitalization; Humans; Idarubicin; Incidence; Length of Stay; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Neutropenia; Remission Induction; Tretinoin | 1999 |
Population pharmacokinetics of amikacin in patients with haematological malignancies.
Topics: Adult; Aged; Amikacin; Anti-Bacterial Agents; Female; Hematologic Neoplasms; Humans; Male; Middle Aged; Models, Biological; Neutropenia; Opportunistic Infections; Reproducibility of Results; Retrospective Studies | 1999 |
Out-patient management of acute myeloid leukemia after consolidation chemotherapy. Role of a hematologic emergency unit.
Topics: Adult; Ambulatory Care; Amikacin; Anemia; Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; Ceftriaxone; Cerebral Hemorrhage; Clinical Trials as Topic; Drug Therapy, Combination; Emergency Service, Hospital; Fever; Hospitalization; Humans; Immunocompromised Host; Italy; Leukemia, Myeloid; Leukocyte Count; Middle Aged; Mycoses; Neutropenia; Staphylococcal Infections | 1999 |
Efficacy of cefepime and amikacin in the empiric treatment of febrile neutropenic children with cancer.
Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Bacteremia; Cefepime; Cephalosporins; Child; Child, Preschool; Drug Therapy, Combination; Escherichia coli Infections; Female; Fever; Fever of Unknown Origin; Humans; Infant; Male; Neoplasms; Neutropenia; Staphylococcal Infections; Streptococcal Infections; Treatment Outcome | 2000 |
[Cost of antibiotic therapy in neutropenic patients undergoing peripheral blood stem cell transplantation for breast cancer].
Topics: Amikacin; Antineoplastic Agents; Breast Neoplasms; Drug Costs; Drug Therapy, Combination; Female; Fever; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Hematopoietic Stem Cell Transplantation; Hospital Costs; Humans; Neutropenia; Penicillanic Acid; Piperacillin; Spain; Tazobactam; Teicoplanin; Transplantation Conditioning; Treatment Failure; Treatment Outcome; Vancomycin | 2000 |
Increased incidence of bacteraemia due to viridans streptococci in an unselected population of patients with acute myeloid leukaemia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteremia; Ciprofloxacin; Drug Resistance, Microbial; Female; Fluconazole; Humans; Incidence; Leukemia, Myeloid, Acute; Male; Middle Aged; Neutropenia; Penicillins; Streptococcal Infections; Streptococcus; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination | 2000 |
[Clinical analysis of neutropenic fever associated with hematological disorders].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Infective Agents, Urinary; Cefoperazone; Drug Combinations; Drug Therapy, Combination; Female; Fever; Granulocyte Colony-Stimulating Factor; Hematologic Neoplasms; Humans; Male; Middle Aged; Neutropenia; Serum Albumin; Sulbactam | 2001 |
Aeromonas sobria sepsis in a neutropenic patient.
Topics: Acute Disease; Aeromonas; Aged; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Female; Gram-Negative Bacterial Infections; Humans; Leukemia, Myeloid; Neutropenia; Sepsis | 2001 |
Application of the IDSA guidelines for the use of antimicrobial agents in neutropenic patients: impact on reducing the use of glycopeptides.
Topics: Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; Brazil; Cefepime; Ceftazidime; Cephalosporins; Child; Drug Therapy, Combination; Female; Fever; Hospitals, Teaching; Humans; Male; Middle Aged; Neutropenia; Oxacillin; Practice Guidelines as Topic; Teicoplanin; Treatment Outcome; Vancomycin | 2001 |
Recurrent bacteremia caused by Rhodococcus equi in a non-neutropenic patient with acute myeloid leukemia in complete remission.
Topics: Actinomycetales Infections; Adult; Amikacin; Bacteremia; Catheters, Indwelling; Ceftazidime; Cilastatin; Drug Resistance; Drug Therapy, Combination; Erythromycin; Female; Humans; Imipenem; Immunocompromised Host; Leukemia, Myelomonocytic, Acute; Neutropenia; Pneumonia, Bacterial; Recurrence; Rhodococcus equi; Vancomycin | 2002 |
Failure of G-CSF therapy in neutropenia associated with Sjögren's syndrome.
Topics: Amikacin; Anemia; Anti-Bacterial Agents; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Immunocompromised Host; Meropenem; Middle Aged; Neutropenia; Opportunistic Infections; Prednisone; Recombinant Proteins; Sjogren's Syndrome; Thienamycins; Thrombocytopenia; Treatment Failure | 2002 |
[Amikacin in the treatment of febrile complications occurring during the neutropenic phase of acute hemopathies].
Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Bacterial Infections; Female; Fever; Humans; Kanamycin; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Male; Middle Aged; Neutropenia | 1979 |
Antimicrobial therapy of septicemia due to Klebsiella pneumoniae in neutropenic rats.
Topics: Agranulocytosis; Amikacin; Animals; Cefazolin; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Synergism; Drug Therapy, Combination; Female; In Vitro Techniques; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Neutropenia; Rats; Sepsis | 1979 |
[Treatment of febrile episodes in the neutropenic subject: use of the combination of amikacin-colistin-trimethoprim-sulphamethoxazole].
Topics: Agranulocytosis; Amikacin; Colistin; Drug Therapy, Combination; Fever; Humans; Kanamycin; Neutropenia; Sulfamethoxazole; Trimethoprim | 1979 |
The pharmacokinetics of amikacin in children.
Topics: Adolescent; Amikacin; Anemia, Aplastic; Appendicitis; Child; Child, Preschool; Cystic Fibrosis; Female; Half-Life; Humans; Kanamycin; Kidney; Leukemia; Male; Metabolic Clearance Rate; Neoplasms; Neutropenia; Pelvic Inflammatory Disease | 1977 |
Ceftazidime and amikacin as empiric treatment of febrile episodes in neutropenic patients in Saudi Arabia.
Topics: Adult; Amikacin; Ceftazidime; Fever; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Hospitals, University; Humans; Mycoses; Neoplasms; Neutropenia; Saudi Arabia; Sepsis; Treatment Outcome | 1992 |
Single daily dose ceftriaxone plus amikacin treatment of febrile episodes in neutropenic patients attending day hospital for hematologic malignancies.
Topics: Adolescent; Adult; Aged; Amikacin; Antineoplastic Combined Chemotherapy Protocols; Ceftriaxone; Day Care, Medical; Drug Therapy, Combination; Female; Fever; Hematologic Diseases; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Opportunistic Infections; Pilot Projects | 1992 |
[Study of the effect of combination therapy of human granulocyte-colony stimulating factor (G-CSF) and amikacin on experimental pyelonephritis induced by Pseudomonas aeruginosa in neutropenic mice].
Topics: Amikacin; Animals; Combined Modality Therapy; Female; Granulocyte Colony-Stimulating Factor; Mice; Mice, Inbred Strains; Neutropenia; Pseudomonas Infections; Pyelonephritis | 1990 |
Ceftriaxone plus amikacin in neutropenic patients: a report on 100 cases.
Topics: Acute Disease; Adolescent; Adult; Aged; Amikacin; Bacterial Infections; Ceftriaxone; Child; Drug Therapy, Combination; Humans; Leukemia; Lymphoma, Non-Hodgkin; Middle Aged; Neutropenia | 1991 |
Amikacin pharmacokinetics in patients receiving high-dose cancer chemotherapy.
Topics: Adolescent; Adult; Aged; Amikacin; Analysis of Variance; Antineoplastic Agents; Body Weight; Female; Half-Life; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Regression Analysis | 1991 |
Using teicoplanin for empiric therapy of febrile neutropenic patients with haematological malignancies.
Topics: Acute Disease; Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; Bacteria; Bone Marrow Transplantation; Ceftazidime; Child; Drug Therapy, Combination; Female; Fever; Glycopeptides; Gram-Positive Bacteria; Humans; Leukemia; Male; Microbial Sensitivity Tests; Middle Aged; Neutropenia; Retrospective Studies; Sepsis; Teicoplanin | 1990 |
Circadian variation in serum amikacin levels.
Topics: Amikacin; Circadian Rhythm; Female; Humans; Male; Middle Aged; Neutropenia; Time Factors | 1990 |
[Combined chemotherapy of experimental infection in neutropenia].
Topics: Agranulocytosis; Amikacin; Animals; Azlocillin; Cefotaxime; Drug Synergism; Drug Therapy, Combination; Escherichia coli Infections; Immune Tolerance; Klebsiella Infections; Mice; Neutropenia; Opportunistic Infections; Pseudomonas Infections | 1989 |
Combination antibiotic treatment of chemotherapy-induced neutropenia in non-leukemic patients.
Topics: Adult; Aged; Agranulocytosis; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Ceftazidime; Clindamycin; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Neutropenia; Prognosis; Prospective Studies | 1989 |
[Infections in neutropenic children with neoplasms. Case series contribution].
Topics: Adolescent; Adult; Agranulocytosis; Amikacin; Bacterial Infections; Ceftazidime; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Leukemia; Lymphoma; Male; Neoplasms; Neutropenia | 1988 |
Ceftazidime and amikacin alone and in combination against Pseudomonas aeruginosa and Enterobacteriaceae.
Topics: Amikacin; Animals; Ceftazidime; Drug Synergism; Drug Therapy, Combination; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Klebsiella Infections; Klebsiella pneumoniae; Neutropenia; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits; Serratia marcescens | 1987 |
Pseudomonas peritonitis in neutropenic rats treated with amikacin, ceftazidime and ticarcillin, alone and in combination.
Topics: Agranulocytosis; Amikacin; Animals; Ceftazidime; Drug Therapy, Combination; Female; Kinetics; Microbial Sensitivity Tests; Neutropenia; Penicillins; Peritoneal Cavity; Peritonitis; Pseudomonas aeruginosa; Pseudomonas Infections; Rats; Rats, Inbred Strains; Ticarcillin | 1987 |
In vivo and in vitro activity of ciprofloxacin plus azlocillin against 12 streptococcal isolates in a neutropenic site model.
Topics: Amikacin; Animals; Azlocillin; Ciprofloxacin; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Enterococcus faecalis; Female; Gentamicins; Kinetics; Neutropenia; Penicillin G; Rabbits; Streptococcal Infections; Streptococcus; Streptococcus pneumoniae | 1987 |
Bacteremia in neutropenic patients at a major teaching hospital--1981 to 1987.
Topics: Agranulocytosis; Amikacin; Australia; Cefotaxime; Drug Therapy, Combination; Gentamicins; Hospitals, Teaching; Humans; Neutropenia; Piperacillin; Sepsis; Ticarcillin | 1988 |
Correlation of antibiotic synergy in vitro and in vivo: use of an animal model of neutropenic gram-negative sepsis.
Topics: Agranulocytosis; Amikacin; Animals; Drug Synergism; Drug Therapy, Combination; Enterobacteriaceae Infections; Imipenem; Kanamycin; Kinetics; Klebsiella Infections; Microbial Sensitivity Tests; Neutropenia; Pseudomonas Infections; Rats; Sepsis; Serratia marcescens; Thienamycins | 1986 |
Efficacy of single-agent therapy with azlocillin, ticarcillin, and amikacin and beta-lactam/amikacin combinations for treatment of Pseudomonas aeruginosa bacteremia in granulocytopenic rats.
Topics: Agranulocytosis; Amikacin; Animals; Azlocillin; Drug Therapy, Combination; Female; Kanamycin; Microbial Sensitivity Tests; Neutropenia; Penicillin Resistance; Penicillins; Pseudomonas Infections; Rats; Rats, Inbred Strains; Sepsis; Ticarcillin | 1986 |
In vitro models for the study of combination antibiotic therapy in neutropenic patients.
Topics: Agranulocytosis; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Azlocillin; Bacterial Infections; Carbenicillin; Cefazolin; Cephalothin; Drug Therapy, Combination; Gentamicins; Humans; Models, Biological; Neutropenia; Pseudomonas Infections; Risk | 1986 |
Combination antibiotic therapy in pediatrics.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Child; Child, Preschool; Cystic Fibrosis; Drug Synergism; Drug Therapy, Combination; Humans; Immunologic Deficiency Syndromes; Infant; Infant, Newborn; Kanamycin; Lactams; Neutropenia; Peritoneal Dialysis, Continuous Ambulatory; Pseudomonas Infections; Risk | 1986 |
Mezlocillin, ceftizoxime, and amikacin alone and in combination against six Enterobacteriaceae in a neutropenic site in rabbits.
Topics: Agranulocytosis; Amikacin; Animals; Cefotaxime; Ceftizoxime; Drug Combinations; Enterobacteriaceae; Female; Hydrogen-Ion Concentration; Kanamycin; Mezlocillin; Microbial Sensitivity Tests; Neutropenia; Rabbits | 1985 |
Comparative activities of piperacillin, ceftazidime, and amikacin, alone and in all possible combinations, against experimental Pseudomonas aeruginosa infections in neutropenic rats.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Ceftazidime; Drug Therapy, Combination; Female; Neutropenia; Penicillin Resistance; Peritonitis; Piperacillin; Pseudomonas Infections; Rats; Rats, Inbred Strains; Sepsis | 1985 |
Forecast of antibiotic susceptibility of translocating strains of enterobacteria and pseudomonas in leukemic neutropenic patients.
Topics: Agranulocytosis; Amikacin; Ampicillin; Anti-Bacterial Agents; Cefotaxime; Enterobacteriaceae; Feces; Gentamicins; Humans; Leukemia; Microbial Sensitivity Tests; Neutropenia; Pseudomonas | 1985 |
Treatment of pediatric infections with amikacin as first-line aminoglycoside.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Chicago; Child; Drug Resistance, Microbial; Drug Synergism; Drug Utilization; Gram-Negative Bacteria; Hospitals, Pediatric; Humans; Infant, Newborn; Kanamycin; Microbial Sensitivity Tests; Neutropenia; Pediatrics; Pseudomonas; Staphylococcus | 1985 |